
    
      Healthy elderly individuals who are eligible to use of statin for primary prevention will be
      enrolled. They are randomly assigned to moderate intensity statin group and low intensity
      statin group by 1:1 manner. Blood tests, physical examinations, and evaluation of statin
      associated muscle symptoms are conducted every 3 months after enrollment. General medical
      care for prevention of cardiovascular disease is continued after 6 months. The accrual period
      is 2 years and follow-up period is 4 years, so the total study period is 6 years.
    
  